Prognostic relevance of transforming genes.
Schlegel
U
U
Neurologische Universitätsklinik, Bonn, Germany.
Neumann
J
J
Kindermann
D
D
Wolf
H K
HK
Baumann
A
A
Forster
F
F
Fimmers
R
R
D001254:Astrocytoma / Q000235:genetics* / Q000401:mortality; D001932:Brain Neoplasms / Q000235:genetics* / Q000401:mortality*; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000235:genetics; D066246:ErbB Receptors / Q000096:biosynthesis / Q000235:genetics; D016158:Genes, p53; D005909:Glioblastoma / Q000235:genetics* / Q000401:mortality; D006801:Humans; D015993:Life Tables; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics*; D009364:Neoplasm Recurrence, Local; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000235:genetics*; D009857:Oncogenes; D011110:Polymorphism, Genetic; D011379:Prognosis; D016019:Survival Analysis; D016211:Transforming Growth Factor alpha / Q000096:biosynthesis / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis / Q000235:genetics
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D016211:Transforming Growth Factor alpha; D016159:Tumor Suppressor Protein p53; D066246:ErbB Receptors